Quaker Chemical Faces Analyst Price Target Reductions Amid Market Pressures

Financial analysts have revised their outlook on Quaker Chemical, with Jefferies leading a recent adjustment by lowering its price target for the specialty chemicals provider. This move reflects ongoing challenges within the market that are impacting short-term growth projections for the company.

Despite reducing its target from $167 to $164 per share on Thursday, Jefferies maintained its “Buy” recommendation, indicating sustained confidence in Quaker Chemical’s long-term business trajectory. The bank cited persistently difficult organic growth conditions as the primary reason for the revised target, noting that significant near-term improvement appears unlikely.

The price target adjustment coincides with a 2% reduction in EBITDA forecasts for the years 2025 through 2027. These revised projections suggest increasing—though manageable—market headwinds that are affecting the company’s financial outlook. Market observers anticipate that investor discussions in the coming winter months will center around Quaker Chemical’s ability to gain market share.

Quaker Chemical’s second quarter 2025 results presented a mixed performance that disappointed some market expectations. Earnings per share (EPS) of $1.71 fell short of the projected $1.86, representing an 8.06% miss. Conversely, revenue outperformed expectations, reaching $483.4 million compared to forecasts of $462.13 million—a 4.6% positive surprise.

Should investors sell immediately? Or is it worth buying Quaker Chemical?

Key Q2 2025 Financial Metrics:
* Net sales: $483.4 million (4% year-over-year increase)
* Organic sales volume: +2% growth driven by new business
* Net loss: $66.6 million (primarily due to an $88.8 million goodwill impairment charge in EMEA)
* Adjusted EBITDA: $75.5 million (10% decrease compared to Q2 2024)
* Gross margins: Slight decline year-over-year

Regional performance varied significantly across Quaker Chemical’s operations. The Asia/Pacific region demonstrated particularly strong results with net sales surging 20% during the second quarter, fueled by increased sales volumes and recent acquisitions. The EMEA region posted more modest growth with approximately 1% revenue increase, supported by higher sales volumes and favorable currency translation effects.

In response to market conditions, Quaker Chemical is implementing a new cost-saving initiative expected to yield $5-8 million in savings during 2025. The company has further plans to achieve approximately $20 million in additional annual savings by the end of 2026. These measures are designed to counter market softness and enhance overall profitability.

Looking ahead to 2026, Jefferies anticipates investor attention will shift toward Quaker Chemical’s long-term strategies for improving return on invested capital (ROIC) and growing free cash flow. Despite current market challenges, the company projects stronger performance in the second half of 2025, with full-year results expected to approach 2024 levels. Quaker Chemical reaffirms its long-term organic growth target of 2-4% and continues to target EBITDA margins in the mid-teens range.